Insulet Corporation (PODD)
Insulet Corporation at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Insulet Corporation (PODD) is a Medical - Devices company based in US with a market capitalization of $9.9B. Revenue grew 30.7% year-over-year and the company generated $377.7M in free cash flow. This page tracks PODD's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 5.4K employees · IPO May 15, 2007
Valuation
Valuation & price
$147.46as of May 17, 2026· -58.2% vs 52w high
42.9
P/E ratio
Latest-FY diluted EPS
6.53
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$9.9B
Market cap
30.7%
Revenue growth (YoY)
71.6%
Gross margin
$377.7M
Free cash flow (USD)
$334.7M
Net debt
0.4%
Share dilution
2/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
2
Insider buys · 90 days
1
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 6, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJun 25, 2026Filing
Director Appointment
- Insider sellJun 4, 2026Filing
Insider Sell $60KBORIO LUCIANA · Director · $59.9K
- Insider buyJun 4, 2026Filing
Insider Buy $400KSTONESIFER TIMOTHY C. · Director · $400.4K
- Insider buyJun 3, 2026Filing
Insider Buy $497KWEATHERMAN ELIZABETH H · Director · $497.5K
- 8-K eventMay 26, 2026Filing
Medical Device Correction
- 8-K eventMay 21, 2026Filing
Bylaw Amendments
- 8-K eventMay 6, 2026Filing
Earnings Release
- Quarterly reportMay 6, 2026Filing
10-Q Filed
- 8-K eventApr 29, 2026Filing
Medical Device Correction
Questions
Frequently asked questions
What is Insulet Corporation's market cap?
Insulet Corporation (PODD) has a market capitalization of $9.9B.
What is PODD's P/E ratio?
PODD trades at a price-to-earnings ratio of 42.9, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is PODD's price-to-book (P/B) ratio?
PODD trades at 6.53 times book value per share.
Are insiders buying PODD stock?
Yes — SEC Form 4 filings show 2 open-market insider buys and 1 sell at Insulet Corporation in the last 90 days.
Same arena
Related companies in Medical - Devices
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.